“Global human microbiome therapeutics market set to grow to $1bn by 2024,” according to Visiongain

Ads

You May Also Like

Changes to the Nomination Committee for Immunicum AB (publ)

Press Release 30 January 2019 Changes to the Nomination Committee for Immunicum AB (publ) ...

NewLink Genetics Announces FDA Orphan-Drug Designation for Indoximod 

AMES, Iowa, Oct. 30, 2017 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (NASDAQ:NLNK) today announced ...